Fast Track designation granted to aTyr Pharma

The Food and Drug Administration granted Fast Track designation to aTyr Pharma Inc.'s (Nasdaq: LIFE) limb girdle muscular dystrophy treatment Resolaris. Shares of the biotherapeutics company climbed 80 cents to close at $3.25.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.